Clinical Trial Update: Umbilical Cord Blood Mononuclear Cells for Hypoxic Neurologic Injury in Infants With Congenital Diaphragmatic Hernia (CDH) [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating Umbilical Cord Blood Mononuclear Cells for hypoxic neurologic injury in infants with congenital diaphragmatic hernia has been termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Diaphragmatic Hernia

Drugs mentioned

• Umbilical Cord Blood Mononuclear Cells

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Congenital Diaphragmatic Hernia | Phase 1 | Status: TERMINATED